Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY01021 Dose-finding in COH for ART
NCT07236476Phase 2Active, not recruiting
- Sponsor
- Luye Pharma Group
- Start
- Oct 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linzagolix in female infertility, sponsored by Luye Pharma Group. Started Oct 2024; status: active, not recruiting.
02
Drugs
linzagolix
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT07236476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07236476.